Paricalcitol in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00064376 · COMPLETED

Trial details

NCT number: NCT00064376
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes

Start date: 2003-05-01
Primary completion: 2005-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.